In This Section
RAPID RESPONSE: Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules
October 15, 2020 12:30 PM to 2:00 PM
Exploring the Changes Hidden in the August 3, 2020 Final USPTO Fee Rules
The USPTO published a Final Rule for "Setting and Adjusting Patent Fees During Fiscal Year 2020" on August 3, 2020, in a Federal Register Notice, announcing fee changes that take effect October 2, 2020. However, the Final Rule contained more than just the usual fee raises. The Final Rule established three other important changes for patent practitioners that could be missed without a careful review, and went largely unnoticed by the patent community. This webinar will provide information about these changes that take effect starting in 2022, including a non-DOCX filing surcharge, a new biennial patent practitioner registration statement requirement, and a voluntary CLE certification for registered practitioners. Speakers will explore the details outlined in the August 3 Final Rule, details that still need clarification by the USPTO, and potential implications for patent applicants and practitioners.
Moderator:
Brian Stanton, Stanton Consulting Services
Speakers:
Terry Clark, Bass, Berry & Sims – Biennial Registration Statement
Theresa Stadheim, Mueting Raasch Group – Voluntary CLE Certification
Brad Forrest, Schwegman Lundberg & Woessner, P.A. – Non-DOCX Filing Surcharge
Add to:
News
-
AIPLA Submits Letter to US Senate Judiciary Committee on Squires Nomination to the USPTO
June 16, 2025
Arlington, VA. June 11, 2025 –The American Intellectual Property Law Association (AIPLA) submitted a letter in response to the nomination of John A. Squires as Director of the United States Patent & Trademark Office (“USPTO”). In view of his impressive background, AIPLA believes Mr. Squires is fully capable of undertaking this important role and appreciates the Senate Judiciary Committee giving this nominee prompt consideration. -
AIPLA Comments on Draft NMPA Measures
June 9, 2025
Arlington, VA. May 17, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the National Medical Products Administration’s (NMPA) draft measures on the protection of drug trial data in China. -
AIPLA Comments to the Copyright Office on the CASE Act Study
May 12, 2025
Arlington, VA. May 9, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office Notice of Inquiry and Request for Comments: CASE Act Study (the “Notice”) related to the Copyright Claims Board. -
AIPLA Files Amicus Brief in Pegasystems Inc. v. Appian Corporation
April 29, 2025
Arlington, VA. April 24, 2025 –The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Supreme Court of Virginia in Pegasystems Inc. v. Appian Corporation, an appeal concerning issues of trade secret misappropriation damages under the Virginia Uniform Trade Secrets Act (VUTSA). -
AIPLA Comments to the USPTO on the WIPO GRTK Treaty
March 21, 2025
Arlington, VA. March 18, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge.